- Home
- WSFS vs PTGX Comparison
WSFS vs PTGX Comparison
Compare WSFS & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSFS
- PTGX
- Stock Information
- Founded
- WSFS 1980
- PTGX 2006
- Country
- WSFS United States
- PTGX United States
- Employees
- WSFS N/A
- PTGX N/A
- Industry
- WSFS Major Banks
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- WSFS Finance
- PTGX Health Care
- Exchange
- WSFS Nasdaq
- PTGX Nasdaq
- Market Cap
- WSFS 2.7B
- PTGX 2.9B
- IPO Year
- WSFS N/A
- PTGX 2016
- Fundamental
- Price
- WSFS $52.89
- PTGX $47.47
- Analyst Decision
- WSFS Hold
- PTGX Strong Buy
- Analyst Count
- WSFS 4
- PTGX 8
- Target Price
- WSFS $61.00
- PTGX $66.50
- AVG Volume (30 Days)
- WSFS 307.2K
- PTGX 789.1K
- Earning Date
- WSFS 07-24-2025
- PTGX 05-06-2025
- Dividend Yield
- WSFS 1.29%
- PTGX N/A
- EPS Growth
- WSFS N/A
- PTGX N/A
- EPS
- WSFS 4.44
- PTGX 0.86
- Revenue
- WSFS $987,714,000.00
- PTGX $207,801,000.00
- Revenue This Year
- WSFS N/A
- PTGX N/A
- Revenue Next Year
- WSFS $3.45
- PTGX $50.30
- P/E Ratio
- WSFS $11.91
- PTGX $55.04
- Revenue Growth
- WSFS 4.38
- PTGX N/A
- 52 Week Low
- WSFS $42.21
- PTGX $27.00
- 52 Week High
- WSFS $62.75
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- WSFS 49.32
- PTGX 58.60
- Support Level
- WSFS $51.75
- PTGX $45.43
- Resistance Level
- WSFS $54.22
- PTGX $46.80
- Average True Range (ATR)
- WSFS 1.36
- PTGX 1.54
- MACD
- WSFS -0.29
- PTGX 0.34
- Stochastic Oscillator
- WSFS 21.47
- PTGX 94.26
About WSFS WSFS Financial Corporation
WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: WSFS Bank provides loans and leases and other financial products to commercial and consumer customers. Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and Wealth Management provides a broad array of planning and advisor services, investment management, personal and institutional trust services, and credit and deposit products to individuals, corporate, and institutional clients. Majority revenue is generated from WSFS Bank segment.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.